Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
BioHiTech Global Inc is a pollution & treatment controls business based in the US. BioHiTech Global shares (BHTG) are listed on the NASDAQ and all prices are listed in US Dollars. BioHiTech Global employs 42 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $0.53 |
|---|---|
| 52-week range | $0.65 - $4.03 |
| 50-day moving average | $1.04 |
| 200-day moving average | $1.33 |
| Wall St. target price | $3.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.33 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.53 from 2022-01-25
| 1 week (2022-01-15) | N/A |
|---|---|
| 1 month (2021-12-23) | -33.32% |
| 3 months (2021-10-22) | N/A |
| 6 months (2021-07-26) | -61.59% |
| 1 year (2021-01-26) | -73.76% |
|---|---|
| 2 years (2020-01-24) | -73.23% |
| 3 years (2019-01-25) | 2.5226 |
| 5 years (2017-01-26) | 2.8 |
| Revenue TTM | $13.5 million |
|---|---|
| Gross profit TTM | $226,403 |
| Return on assets TTM | -7.96% |
| Return on equity TTM | -158.21% |
| Profit margin | -60.72% |
| Book value | $0.01 |
| Market capitalisation | $24.6 million |
TTM: trailing 12 months
We're not expecting BioHiTech Global to pay a dividend over the next 12 months.
Over the last 12 months, BioHiTech Global's shares have ranged in value from as little as $0.6501 up to $4.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioHiTech Global's is 1.1834. This would suggest that BioHiTech Global's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
BioHiTech Global, Inc. , through its subsidiaries, provides environmental management solutions worldwide. The company's suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. It markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level. The company serves healthcare, grocery, prison, retail food service, education, and hospitality sectors, as well as food distributors, convention centers, hotels, restaurants, stadiums, and municipalities and academic institutions. BioHiTech Global, Inc. is headquartered in Chestnut Ridge, New York.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.